1007 related articles for article (PubMed ID: 25454502)
1. Effectiveness of levetiracetam use following resective surgery in patients with refractory epilepsy: a prospective observational study.
Zeng TF; Li YH; An DM; Chen L; Lei D; Zhang B; Li JM; Zhou D
Epilepsy Res; 2014 Dec; 108(10):1904-11. PubMed ID: 25454502
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of different antiepileptic drug strategies in medically refractory epilepsy patients following epilepsy surgery.
Zeng TF; An DM; Li JM; Li YH; Chen L; Hong Z; Lei D; Zhou D
Epilepsy Res; 2012 Aug; 101(1-2):14-21. PubMed ID: 22440744
[TBL] [Abstract][Full Text] [Related]
3. Levetiracetam may favorably affect seizure outcome after temporal lobectomy.
Jehi LE; Irwin AI; Kayyali H; Vadera S; Bingaman W; Najm I
Epilepsia; 2012 Jun; 53(6):979-86. PubMed ID: 22462729
[TBL] [Abstract][Full Text] [Related]
4. Levetiracetam for people with mental retardation and refractory epilepsy.
Kelly K; Stephen LJ; Brodie MJ
Epilepsy Behav; 2004 Dec; 5(6):878-83. PubMed ID: 15582836
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of antiepileptic drug withdrawal following extratemporal resective epilepsy surgery.
Menon R; Rathore C; Sarma SP; Radhakrishnan K
Neurology; 2012 Aug; 79(8):770-6. PubMed ID: 22843256
[TBL] [Abstract][Full Text] [Related]
6. Timing of antiepileptic drug withdrawal and long-term seizure outcome after paediatric epilepsy surgery (TimeToStop): a retrospective observational study.
Boshuisen K; Arzimanoglou A; Cross JH; Uiterwaal CS; Polster T; van Nieuwenhuizen O; Braun KP;
Lancet Neurol; 2012 Sep; 11(9):784-91. PubMed ID: 22841352
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany.
Opp J; Tuxhorn I; May T; Kluger G; Wiemer-Kruel A; Kurlemann G; Gross-Selbeck G; Rating D; Brandl U; Bettendorf U; Härtel C; Korn-Merker E
Seizure; 2005 Oct; 14(7):476-84. PubMed ID: 16182573
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of levetiracetam efficacy in epileptic syndromes with continuous spikes-waves during slow sleep.
Atkins M; Nikanorova M
Seizure; 2011 Oct; 20(8):635-9. PubMed ID: 21752673
[TBL] [Abstract][Full Text] [Related]
10. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
Abou-Khalil B; Hemdal P; Privitera MD
Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
[TBL] [Abstract][Full Text] [Related]
11. Retention rate of levetiracetam in children with intractable epilepsy at 1 year.
Peake D; Mordekar S; Gosalakkal J; Mukhtyar B; Buch S; Crane J; Wheway R; Rittey C; Donnelly J; Whitehouse WP; Philip S
Seizure; 2007 Mar; 16(2):185-9. PubMed ID: 17258474
[TBL] [Abstract][Full Text] [Related]
12. Cognitive consequences of early versus late antiepileptic drug withdrawal after pediatric epilepsy surgery, the TimeToStop (TTS) trial: study protocol for a randomized controlled trial.
Boshuisen K; Lamberink HJ; van Schooneveld MM; Cross JH; Arzimanoglou A; van der Tweel I; Geleijns K; Uiterwaal CS; Braun KP
Trials; 2015 Oct; 16():482. PubMed ID: 26503021
[TBL] [Abstract][Full Text] [Related]
13. Loss of the initial efficacy of levetiracetam in patients with refractory epilepsy.
Lee GH; Kim BM; Kang JK; Lee SA
Seizure; 2013 Apr; 22(3):185-8. PubMed ID: 23280273
[TBL] [Abstract][Full Text] [Related]
14. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of resective epilepsy surgery after invasive presurgical evaluation in children with tuberous sclerosis complex and bilateral multiple lesions.
Arya R; Tenney JR; Horn PS; Greiner HM; Holland KD; Leach JL; Gelfand MJ; Rozhkov L; Fujiwara H; Rose DF; Franz DN; Mangano FT
J Neurosurg Pediatr; 2015 Jan; 15(1):26-33. PubMed ID: 25360852
[TBL] [Abstract][Full Text] [Related]
16. Levetiracetam in refractory epilepsy: a prospective observational study.
Mohanraj R; Parker PG; Stephen LJ; Brodie MJ
Seizure; 2005 Jan; 14(1):23-7. PubMed ID: 15642496
[TBL] [Abstract][Full Text] [Related]
17. Timing of antiepileptic drug withdrawal in adult epilepsy patients after neocortical surgical resection: a critically appraised topic.
Ziemba KS; Wellik KE; Hoffman-Snyder C; Noe KH; Demaerschalk BM; Wingerchuk DM
Neurologist; 2011 May; 17(3):176-8. PubMed ID: 21532391
[TBL] [Abstract][Full Text] [Related]
18. Prospective audits with newer antiepileptic drugs in focal epilepsy: insights into population responses?
Brodie MJ; Kelly K; Stephen LJ
Epilepsy Behav; 2014 Feb; 31():73-6. PubMed ID: 24361766
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.
Milligan TA; Hurwitz S; Bromfield EB
Neurology; 2008 Aug; 71(9):665-9. PubMed ID: 18725591
[TBL] [Abstract][Full Text] [Related]
20. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
